Adaptive Multiple Comparison Sequential Design (AMCSD) for clinical trials

References

• Armitage, P., C. K. McPherson, and B. C. Rowe. 1969. Repeated significance tests on accumulating data. Journal of the Royal Statistical Society (General) 132 (2):235–244.
   Web of Science ®Google Scholar
• Bauer, P., F. Bretz, V. Dragalin, F. König, and G. Wassmer. Twenty-five years of confirmatory adaptive designs: Opportunities and pitfalls. Statistics in Medicine 35(3):325–347. 15 Mar 2015. doi:10.1002/sim.6472.
   PubMed Web of Science ®Google Scholar
• Bretz, F., H. Schmidli, F. Knig, A. Racine, and W. Maurer. 2006. Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: General concepts. Biometrical Journal 48 (4):623–634. doi:10.1002/bimj.200510232.
   PubMed Web of Science ®Google Scholar
• Chen, Y. H., D. L. DeMets, and K. K. G. Lan. 2010. Some drop-the-loser designs for monitoring multiple doses. Statistics in Medicine. 29(17):1793–1807. 10.1002/sim.3958.
   PubMed Web of Science ®Google Scholar
• clinicaltrials.gov. A 3-arm multi-center, randomized controlled study comparing transforaminal corticosteroid, transforaminal etanercept and transforaminal saline for lumbosacral radiculopathy. https://clinicaltrials.gov/ct2/show/NCT00733096
   Google Scholar
• Dunnett, C. W. 1955. A multiple comparison procedure for comparing several treatments with a control. Journal of the American Statistical Association. 50 (272):1096–1121. doi:10.1080/01621459.1955.10501294.
   Web of Science ®Google Scholar
• European medicines agency. 2020. Call to pool research resources into large multi-centre, multi-arm clinical trials to generate sound evidence on COVID-19 treatments. Media and Public Relations. (March 19).
   Google Scholar
• Freidlin, B., E. L. Korn, R. Gray, and A. Martin. Jul 15, 2008. Multi-arm clinical trials of new agents: Some design considerations. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 14 (14):4368–4371. doi:10.1158/1078-0432.CCR-08-0325.
   PubMed Web of Science ®Google Scholar
• Gao, P., L. Y. Liu, and C. Mehta. 2013. Exact inference for adaptive group sequential designs. Statistics in Medicine 32 (23):3991–4005. 15 October 2013. doi:10.1002/sim.5847.
   PubMed Web of Science ®Google Scholar
• Gao, P., L. Y. Liu, and C. Mehta. 2014. Adaptive sequential testing for multiple comparisons. Journal of Biopharmaceutical Statistics 24 (5):1035–1058. doi:10.1080/10543406.2014.931409.
   PubMed Web of Science ®Google Scholar
• Gao, P., J. H. Ware, and C. Mehta. 2008. Sample size re-estimation for adaptive sequential designs. Journal of Biopharmaceutical Statistics 18 (6):1184–1196. 2008. doi:10.1080/10543400802369053.
   PubMed Web of Science ®Google Scholar
• Ghosh, P., L. Y. Liu, P. Senchaudhuri, P. Gao, and C. Mehta. December 2017. Design and monitoring of multi-arm multi-stage clinical trials. Biometrics 73(4):1289–1299. doi: 10.1111/biom.12687.
   PubMed Web of Science ®Google Scholar
• Hayter, A. J. 1986. The maximum familywise error rate of Fisher's least significant difference test. Journal of the American Statistical Association 81:1001–1004.
   Web of Science ®Google Scholar
• Huffer, F. 1986. Slepian’s inequality via the central limit theorem. Canadian Journal of Statistics 367–370. doi:10.2307/3315195.
   Web of Science ®Google Scholar
• Jaki, T., and L. V. Hampson. 2016. Designing multi-arm multi-stage clinical trials using a risk–benefit criterion for treatment selection. Statistics in Medicine 35 (4):522–533. doi:10.1002/sim.6760.
   PubMed Web of Science ®Google Scholar
• Jaki, T., and J. M. S. Wason. Multi-arm multi-stage trials can improve the efficiency of finding effective treatments for stroke: A case study. BMC Cardiovascular Disorders 18(1):215. 2018 Nov 27. doi:10.1186/s12872-018-0956-4.
   PubMedGoogle Scholar
• Jennison, C., and B. W. Turnbull. 1997. Group sequential analysis incorporating covariance information. Journal of the American Statistical Association 92 (440):1330–1441. doi:10.1080/01621459.1997.10473654.
   Web of Science ®Google Scholar
• Jennison, C., and B. W. Turnbull. 2000. Group sequential methods with applications to clinical trials. Boca Raton, FL: Chapman & Hall/CRC. doi:10.1201/9781584888581.
   Google Scholar
• Magirr, D., T. Jaki, and J. Whitehead. 2012. A generalized Dunnett test for multi-arm multi-stage clinical studies with treatment selection. Biometrika (2012) 99 (2):494–501. doi:10.1093/biomet/ass002.
   Web of Science ®Google Scholar
• Marcus, R., E. Peritz, and K. R. Gabriel. 1976. On closed testing procedures with special reference to ordered analysis of variance. Biometrika 63 (3):655–660. doi:10.1093/biomet/63.3.655.
   Web of Science ®Google Scholar
• Moore, T. J., H. Zhang, G. Anderson, and G. C. Alexander. 2018. Estimated costs of pivotal trials for novel therapeutic agents approved by the us food and drug administration, 2015-2016. JAMA Internal Medicine 178 (11):1451–1457. doi:10.1001/jamainternmed.2018.3931.
   PubMed Web of Science ®Google Scholar
• National Institute of Health. n.d. The multi-arm optimization of stroke thrombosis. https://www.nihstrokenet.org/most/most
   Google Scholar
• O’Brien, P. C., and T. R. Fleming. Sep 1979. A multiple testing procedure for clinical trials. Biometrics 35(3):549–556. doi: 10.2307/2530245.
   PubMed Web of Science ®Google Scholar
• Pocock, S. J. 1977. Group sequential methods in the design and analysis of clinical trials. Biometrika 64 (2):191–199. doi:10.1093/biomet/64.2.191.
   Web of Science ®Google Scholar
• Slepian, D. 1962. The one-sided barrier problem for Gaussian Noise. Bell System Technical Journal 41 (2):463–501. doi:10.1002/j.1538-7305.1962.tb02419.x.
   Google Scholar
• Stallard, N., and T. Friede. 2008. A group-sequential design for clinical trials with treatment selection. Statistics in Medicine 27 (29):6209–6227. doi:10.1002/sim.3436.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services Food and Drug Administration (CDER and CBER). 2019. Enrichment strategies for clinical trials to support determination of effectiveness of human drugs and biological products guidance for industry. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enrichment-strategies-clinical-trials-support-approval-human-drugs-and-biological-products
   Google Scholar
• U.S. department of health and human services food and drug administration (CDER and CBER). 2019. Guidance for Industry Adaptive Design Clinical Trials for Drugs and Biologics.
   Google Scholar
• Wason, J., D. Magirr, M. Law, and T. Jaki. 2016. Some recommendations for multi-arm multi-stage trials. Statistical Methods in Medical Research 25 (2):716–727. doi:10.1177/0962280212465498.
   PubMed Web of Science ®Google Scholar
• Wason, J., N. Stallard, J. Bowden, and C. Jennison. 2017. A multi-stage drop-the-losers design for multi-arm clinical trials. Statistical Methods in Medical Research 26 (1):508–524. doi:10.1177/0962280214550759.
   PubMed Web of Science ®Google Scholar
• Whitehead, J. 1997. The design and analysis of sequential clinical trials. Rev. 2nd ed. England, West Sussex: John Wiley & Sons Ltd.
   Google Scholar